Has Sumana Reddy, DO received payments from drug or device companies?

Yes. Drug and device makers reported $10,335 in general payments to Sumana Reddy, DO across 458 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sumana Reddy, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sumana Reddy, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sumana Reddy, DO

Endocrinology, Diabetes & Metabolism · Jonesboro, GANPI 1588741888

Payments from drug & device makers

$10,335in general payments, 2019–2025

Across 458 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$1K
Novo Nordisk$1K
Tandem Diabetes Care, Inc.$948
Xeris Pharmaceuticals, Inc.$591
Corcept Therapeutics$515
Sanofi-aventis U.S. LLC$513
plus $5K from 48 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	70	$1,297
Novo Nordisk	54	$1,029
Tandem Diabetes Care, Inc.	19	$948
Xeris Pharmaceuticals, Inc.	29	$591
Corcept Therapeutics	19	$515
Sanofi-aventis U.S. LLC	24	$513
Abbott	17	$511
Amgen(2 entities)	27	$482
Radius Health, Inc.	12	$395
Insulet Corporation	14	$344
Mannkind Corporation	15	$331
Bigfoot Biomedical Inc	5	$262
Astellas Pharma US Inc	9	$236
Boehringer Ingelheim	12	$223
BETA Bionics, Inc.	3	$202
AbbVie	13	$187
Amneal Pharmaceuticals LLC	9	$175
AstraZeneca	12	$164
Bayer	7	$151
IBSA Pharma Inc.	7	$137
Novartis	6	$118
Madrigal Pharmaceuticals	3	$106
Merck	5	$102
Dexcom, Inc.	6	$98
Ascendis Pharma Endocrinology Inc	4	$87
Ultragenyx Pharmaceutical Inc.	4	$84
Pfizer	4	$74
Chiesi USA, Inc.	3	$67
CSL Behring	1	$60
Antares Pharma, Inc.	3	$58
Medtronic	3	$55
Companion Medical, Inc.	1	$54
Neurocrine Biosciences, Inc.	2	$54
Sequel Med Tech, LLC	2	$51
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$49
Sumitomo Pharma America, Inc.	2	$48
Amarin Pharma, Inc.	2	$44
Shire North American Group Inc	3	$44
Recordati_rare_diseases_inc.	3	$41
Cequr Corporation	3	$40
Idorsia Pharmaceuticals US Inc	2	$33
GSK	2	$31
Amphastar Pharmaceuticals, Inc.	1	$30
EUSA Pharma (US) LLC	2	$27
Kyowa Kirin, Inc.	2	$26
Dynavax Technologies Corporation	1	$25
Endo Pharmaceuticals Inc.	1	$25
Verity Pharmaceuticals Inc.	1	$23
Halozyme Inc	1	$21
Mylan Specialty L.p.	1	$16
Nevro Corp.	1	$16
Valeritas, Inc.	1	$13
Johnson & Johnson	1	$13
Vivus LLC	1	$10

How this compares

$10,335 in reported general payments places this provider in the 75th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.

See all endocrinology, diabetes & metabolism providers in Georgia →

Medicare billing

Part B allowed, 2024

$99,869

Medicare patients

282

Services billed

2,462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Jonesboro

Bruce BodeAtlanta$18.3M
Gulliermo UmpierrezAtlanta$6.6M
John ReedRoswell$5.7M
Thomas JonesMacon$4.8M
Steven LeichterColumbus$3.1M
Jason BernerJasper$2.6M
Ashwini GoreMacon$2.6M
Adeniyi OdugbesanLawrenceville$1.8M
David RobertsonAtlanta$1.7M
Thomas ZieglerAtlanta$1M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →